Dopamine promotes osteogenic differentiation of PDLSCs by activating DRD1 and DRD2 during orthodontic tooth movement via ERK1/2 signaling pathway
Regenerative Therapy · 2024-12 · 27 · 268-278
DOI: 10.1016/j.reth.2024.03.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Therapy, 2024-12. Verfasst von Hanfei Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Orthodontic tooth movement (OTM) involves complex interactions between mechanical forces and periodontal tissue adaptation, mainly mediated by periodontal ligament cells, including periodontal ligament stem cells (PDLSCs), osteoblasts, and osteoclasts. Dopamine (DA), a neurotransmitter known for its critical role in bone metabolism, is investigated in this study for its potential to enhance osteogenic differentiation in PDLSCs, which are pivotal in OTM. This study examined the potential of DA to facilitate OTM by binding to DA receptors (D1R and D2R) and activating the ERK1/2 signaling pathway. We propose that DA's interaction with these receptors on PDLSCs could enhance osteogenic differentiation, thereby accelerating bone remodeling and reducing the duration of orthodontic treatments, which offering a novel approach to improve clinical outcomes in orthodontic care.
Methods
This study utilized a rat OTM model, micro-CT, histological analyses, and in vitro assays to investigate dopamine's effect on osteogenesis. PDLSCs were cultured and treated with DA, and cytotoxicity, osteogenic differentiation, gene and protein expression assessed.
Results
Dopamine administration significantly increased trabecular bone density and osteogenic marker expression in an OTM rat model. In vitro, DA at 10 nM optimally promoted human PDLSCs osteogenesis without affecting proliferation. Blocking DA receptors or inhibiting the ERK1/2 pathway attenuated these effects, underscoring the importance of dopaminergic signaling in tension-induced osteogenesis during OTM.
Conclusion
Taken together, our study reveals that local dopamine administration at a concentration of 10 nM not only enhances tension-induced osteogenesis in vivo but also significantly promotes osteogenic differentiation of PDLSCs in vitro through D1 and D2 receptor-mediated ERK1/2 signaling pathway activation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stomatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Sun, H., Feng, Y., Tu, S., Zhou, J., Wang, Y., Wei, J., Zhang, S., Hou, Y., Shao, Y., Ai, H., & Chen, Z. (2024). Dopamine promotes osteogenic differentiation of PDLSCs by activating DRD1 and DRD2 during orthodontic tooth movement via ERK1/2 signaling pathway. Regenerative Therapy, 27, 268-278. https://doi.org/10.1016/j.reth.2024.03.025
Vancouver
Sun H, Feng Y, Tu S, Zhou J, Wang Y, Wei J, et al. Dopamine promotes osteogenic differentiation of PDLSCs by activating DRD1 and DRD2 during orthodontic tooth movement via ERK1/2 signaling pathway. Regenerative Therapy. 2024;27:268-278. doi:10.1016/j.reth.2024.03.025
BibTeX
@article{Sun2024,
author = {Sun, Hanfei and Feng, Yi and Tu, Shaoqin and Zhou, Jianwu and Wang, Yuxuan and Wei, Jiaming and Zhang, Sai and Hou, Yuluan and Shao, Yiting and Ai, Hong and Chen, Zheng},
title = {Dopamine promotes osteogenic differentiation of PDLSCs by activating DRD1 and DRD2 during orthodontic tooth movement via ERK1/2 signaling pathway},
journal = {Regenerative Therapy},
year = {2024},
volume = {27},
pages = {268--278},
doi = {10.1016/j.reth.2024.03.025}
}
EUVIMED